Clinical trial · Interventional
Treatment of Dermatofibrosarcoma Protuberans in Patients 10 Years and Younger
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this proposed study is to assess effectiveness of MOHS micrographic surgery as a form of treatment for dermatofibrosarcoma protuberans in patients who are 10 years of age or younger through review of the patients at Mayo Clinic treated from 1988-2017, and to explore the challenges that providers face which may prevent them performing this potentially superior treatment. This study will provide a comparison of outcomes and recurrence rates in pediatric patients treated by MOHS versus traditional excision.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Dermatofibrosarcoma Protuberans | Dermatofibrosarcoma Protuberans | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| MOHS micrographic surgery | Procedure | — | UNRESOLVED |
| Wide local excision | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- MOHS treatment arm
- description
- Patients who have their dermatofibrosarcoma protuberans excised with MOHS surgery.
- interventionNames
- Procedure: MOHS micrographic surgery
- Procedure: Wide local excision
Primary outcomes (1)
- measure
- Patient developing recurrence of a biopsy-proven dermatofibrosarcoma protuberans at one year.
- timeFrame
- Recurrence will be assessed at 1 year.
- description
- Developing an additional dermatofibrosarcoma protuberans at any location, but particularly noting local recurrence (defined as being within or contiguous to the field of the previous excision.
Secondary outcomes (5)
- measure
- All cause mortality
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 1 Year
- Maximum age
- 10 Years
Show eligibility criteria text
Must be 10 years of age or younger. Must have biopsy proven dermatofibrosarcoma protuberans.
References
Publications (0)
Data not yet available